Etoposide User Reviews & Ratings
Brand names: Toposar, Etopophos
Etoposide has an average rating of 7.5 out of 10 from a total of 2 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Small Cell Lung Cancer | 2 reviews for Small Cell Lung Cancer | 11 medications |
- Fin...
- Taken for 1 to 6 months
- March 10, 2025
For Small Cell Lung Cancer "Reduced tumors, all but two. Had over 20. My cancer was carcinoid lung cancer, then small cell, and now neuroendocrine carcinoma. Side effects minimal. Did lose my hair. Who cares."
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about etoposide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
Patient resources
- Etoposide drug information
- Etoposide injection
- Etoposide phosphate
- Etoposide (Intravenous) (Advanced Reading)
- Etoposide (Oral) (Advanced Reading)
- Etoposide Capsules
For Small Cell Lung Cancer "Fatigue and constipation, most frequent side effects."